These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22293163)

  • 1. Sincalide cholescintigraphy--32 years later: evidence-based data on its clinical utility and infusion methodology.
    Ziessman HA
    Semin Nucl Med; 2012 Mar; 42(2):79-83. PubMed ID: 22293163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sincalide: A Review of Clinical Utility, Proper Infusion Methodology, and Alternative Cholecystogogues.
    Ziessman HA
    J Nucl Med Technol; 2019 Sep; 47(3):210-212. PubMed ID: 31019045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sincalide-stimulated cholescintigraphy: a multicenter investigation to determine optimal infusion methodology and gallbladder ejection fraction normal values.
    Ziessman HA; Tulchinsky M; Lavely WC; Gaughan JP; Allen TW; Maru A; Parkman HP; Maurer AH
    J Nucl Med; 2010 Feb; 51(2):277-81. PubMed ID: 20080900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin cholescintigraphy: victim of its own success?
    Ziessman HA
    J Nucl Med; 1999 Dec; 40(12):2038-42. PubMed ID: 10616884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal values for sincalide cholescintigraphy: comparison of two methods.
    Ziessman HA; Muenz LR; Agarwal AK; ZaZa AA
    Radiology; 2001 Nov; 221(2):404-10. PubMed ID: 11687683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional hepatobiliary disease: chronic acalculous gallbladder and chronic acalculous biliary disease.
    Ziessman HA
    Semin Nucl Med; 2006 Apr; 36(2):119-32. PubMed ID: 16517234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calculation of a gallbladder ejection fraction: advantage of continuous sincalide infusion over the three-minute infusion method.
    Ziessman HA; Fahey FH; Hixson DJ
    J Nucl Med; 1992 Apr; 33(4):537-41. PubMed ID: 1552338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin cholescintigraphy: clinical indications and proper methodology.
    Ziessman HA
    Radiol Clin North Am; 2001 Sep; 39(5):997-1006, ix. PubMed ID: 11587066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does gallbladder ejection fraction predict outcome after cholecystectomy for suspected chronic acalculous gallbladder dysfunction? A systematic review.
    DiBaise JK; Oleynikov D
    Am J Gastroenterol; 2003 Dec; 98(12):2605-11. PubMed ID: 14687804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acalculous biliary pain: cholecystectomy alleviates symptoms in patients with abnormal cholescintigraphy.
    Yap L; Wycherley AG; Morphett AD; Toouli J
    Gastroenterology; 1991 Sep; 101(3):786-93. PubMed ID: 1860640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sincalide-Stimulated Cholescintigraphy: A Retrospective Study and Proposal of a Modified Workflow.
    Vasireddi A; Nguyen NC
    Clin Nucl Med; 2022 Jan; 47(1):1-6. PubMed ID: 34874343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallbladder ejection fraction: an accurate evaluation of symptomatic acalculous gallbladder disease.
    Majeski J
    Int Surg; 2003; 88(2):95-9. PubMed ID: 12872903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin-cholescintigraphy in adults: consensus recommendations of an interdisciplinary panel.
    DiBaise JK; Richmond BK; Ziessman HA; Everson GT; Fanelli RD; Maurer AH; Ouyang A; Shamamian P; Simons RJ; Wall LA; Weida TJ; Tulchinsky M
    Clin Nucl Med; 2012 Jan; 37(1):63-70. PubMed ID: 22157031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of gallbladder ejection fraction utilizing cholecystokinin-stimulated magnetic resonance cholangiography and comparison with hepatobiliary scintigraphy.
    Vyas PK; Vesy TL; Konez O; Ciavellara DP; Hua K; Gaisie G
    J Magn Reson Imaging; 2002 Jan; 15(1):75-81. PubMed ID: 11793460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus report on standardization of sincalide cholescintigraphy.
    Ziessman HA; Tulchinsky M; Maurer A
    J Nucl Med; 2011 Aug; 52(8):16N. PubMed ID: 21810583
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis of BD relied in great measure on gallbladder ejection fraction (GBEF) after sincalide stimulation on hepatobiliary scintigraphy.
    Tulchinsky M
    J Pediatr Surg; 2009 Oct; 44(10):2059; author reply 2059-60. PubMed ID: 19853777
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of cholecystokinin-stimulated cholescintigraphy in the diagnosis and treatment of acalculous gallbladder disease.
    Mishkind MT; Pruitt RF; Bambini DA; Hakenewerth AM; Thomason MH; Zuger JH; Novick T
    Am Surg; 1997 Sep; 63(9):769-74. PubMed ID: 9290518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimum utilization of cholecystokinin cholescintigraphy (CCK-HIDA) in clinical practice: an evidence based review.
    Richmond BK
    W V Med J; 2012; 108(2):8-11. PubMed ID: 22655428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Acalculous Cholecystitis in Children With Biliary Symptoms: Usefulness of Hepatocholescintigraphy.
    Kwatra NS; Nurko S; Stamoulis C; Falone AE; Grant FD; Treves ST
    J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):68-73. PubMed ID: 30256266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of stimulated cholescintigraphy using a standardized Ensure-Plus fatty meal protocol in patients with suspected functional gallbladder disorder: a retrospective study of seven-years clinical experience.
    Li AY; Yue H; Kavnoudias H; Cherk MH; Nadebaum DP; Barton H; Beech P; Yap KSK; Smith M; Paul E; Barber TW
    ANZ J Surg; 2022 Apr; 92(4):774-780. PubMed ID: 34850524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.